Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
US Army
AstraZeneca
Chinese Patent Office
Federal Trade Commission
Daiichi Sankyo
Merck
Cerilliant
Baxter

Generated: May 27, 2018

DrugPatentWatch Database Preview

Claims for Patent: 7,994,185

« Back to Dashboard

Summary for Patent: 7,994,185
Title:Benzene sulfonamide thiazole and oxazole compounds
Abstract: The present invention provides thiazole sulfonamide and oxazole sulfonamide compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
Inventor(s): Rheault; Tara Renae (Durham, NC)
Assignee: Glaxo Smith Kline LLC (Philadelphia, PA)
Application Number:12/434,963
Patent Claims: 1. A compound of formula ##STR00609## or a pharmaceutically acceptable salt thereof.

2. A pharmaceutical composition, comprising a compound of claim 1, together with one or more of pharmaceutically acceptable carriers, diluents or excipients.

3. A pharmaceutical composition as claimed in claim 2 in unit dosage form.

4. A method of treatment of a human suffering from melanoma, which comprises administering to said subject an effective amount of a compound as claimed in claim 1.

5. The method of claim 4, wherein the melanoma is metastatic melanoma having a mutation encoding a V600E amino acid substitution.

6. A compound of formula ##STR00610##

7. A pharmaceutical composition, comprising a compound of claim 6, together with one or more of pharmaceutically acceptable carriers, diluents or excipients.

8. A pharmaceutical composition as claimed in claim 7 in unit dosage form.

9. A method of treatment of a human suffering from melanoma, which comprises administering to said subject an effective amount of a compound as claimed in claim 6.

10. The method of claim 9, wherein the melanoma is metastatic melanoma having a mutation encoding a V600E amino acid substitution.

11. A pharmaceutically acceptable salt of the compound of formula ##STR00611##

12. A pharmaceutical composition, comprising a compound of claim 11, together with one or more of pharmaceutically acceptable carriers, diluents or excipients.

13. A pharmaceutical composition as claimed in claim 12 in unit dosage form.

14. A method of treatment of a human suffering from melanoma, which comprises administering to said subject an effective amount of a compound as claimed in claim 11.

15. The method of claim 14, wherein the melanoma is metastatic melanoma having a mutation encoding a V600E amino acid substitution.

16. N-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-y- l]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide mesylate.

17. A pharmaceutical composition, comprising a compound of claim 16, together with one or more of pharmaceutically acceptable carriers, diluents or excipients.

18. A pharmaceutical composition as claimed in claim 16 in unit dosage form.

19. A method of treatment of a human suffering from melanoma, which comprises administering to said subject an effective amount of a compound as claimed in claim 16.

20. The method of claim 19, wherein the melanoma is metastatic melanoma having a mutation encoding a V600E amino acid substitution.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Chinese Patent Office
Medtronic
Deloitte
Express Scripts
Boehringer Ingelheim
Julphar
Dow
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.